EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Modulation of Glucose Homeostasis, Metabolic Endotoxemia and Circulating Short-Chain Fatty Acids Following Multi-Species Probiotic Supplementation: Findings from a 12-Week Randomised Placebo-Controlled Trial

George Moschonis iD, Pauline Dacaya, Thy T Truong, Angela Amoruso iD, Marco Pane iD

Nutrients · 2026

DOI: 10.3390/nu18071025 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von George Moschonis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Dietetics, Harokopio University, 70 El. Venizelou Avenue, 17671 Athens, Greece. Hauptthemen laut MEDLINE: Probiotics, Endotoxemia, Blood Glucose, Homeostasis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Probiotical SpA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Altered gut microbiota and gut-derived inflammation impair glucose regulation and promote metabolic endotoxemia, yet evidence on probiotic effects across combined glycaemic, inflammatory and short-chain fatty acid (SCFA) outcomes remains limited. This study investigated the effects of a 12-week multi-species probiotic on glucose homeostasis, incretin hormones, inflammatory biomarkers and circulating SCFAs in adults with subthreshold depression.

Methods

In a 12-week double-blind, randomised, placebo-controlled trial, 39 adults with subthreshold depression were allocated to either a probiotic supplement containing Limosilactobacillus fermentum LF16, Lacticaseibacillus rhamnosus LR06, Lactiplantibacillus plantarum LP01 and Bifidobacterium longum 04 (n = 19) or placebo (n = 20). Fasting glucose, insulin, HOMA-IR, glucose-dependent insulinotropic peptide (GIP), high-sensitivity C-reactive protein (hs-CRP), lipopolysaccharide-binding protein (LBP), soluble CD14 (sCD14) and SCFAs were evaluated at three time points: baseline, week 6 and week 12. Between-group and treatment × time effects were analysed using general linear models.

Results

Probiotic supplementation significantly reduced fasting glucose at 12 weeks compared with placebo (−1.8 vs. 0.1 mmol/L; p = 0.036). In the probiotic group, greater reductions in GIP (p = 0.012; p = 0.037), LBP (p < 0.001), sCD14 (p = 0.002; p = 0.001) and hs-CRP (p = 0.047) were also observed compared with placebo. Plasma SCFA concentrations remained largely unchanged, with no significant treatment × time interactions, except for higher valerate levels at 12 weeks in the probiotic group (p = 0.019).

Conclusions

Twelve weeks of multi-species probiotic supplementation improved fasting glucose, reduced incretin and inflammatory biomarkers and attenuated metabolic endotoxemia, without alterations in circulating SCFAs. These findings support beneficial modulation of metabolic–immune pathways and highlight the promising role of probiotics to enhance glucose regulation and systemic inflammatory tone in adults with subthreshold depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsEndotoxemiaBlood GlucoseHomeostasisFatty Acids, VolatileHumansMaleDouble-Blind MethodFemaleAdultBiomarkersMiddle AgedDietary SupplementsGastrointestinal MicrobiomeInsulin

Stichwörter der Autor:innen

glucose homeostasisincretin hormonesmetabolic endotoxemiaprobioticsshort-chain fatty acids

Substanzen

Blood GlucoseFatty Acids, VolatileBiomarkersInsulin

Autor:innen und Institutionen

  • Department of Nutrition and Dietetics, Harokopio University, 70 El. Venizelou Avenue, 17671 Athens, Greece.
  • European Centre for Obesity, Harokopio University, 17671 Athens, Greece.
  • Department of Sport, Exercise and Nutrition Sciences, Discipline of Food, Nutrition and Dietetics, School Allied Health, Human Services and Sport, La Trobe University, Melbourne, VIC 3086, Australia.
  • Proteomics and Metabolomics Platform, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne, VIC 3086, Australia.
  • Probiotical Research Srl, 28100 Novara, Italy.

ORCID-Profile: George Moschonis, Angela Amoruso, Marco Pane

Förderung

  • Probiotical SpA

Zitieren

APA

Moschonis, G., Dacaya, P., Truong, T. T., Amoruso, A., & Pane, M. (2026). Modulation of Glucose Homeostasis, Metabolic Endotoxemia and Circulating Short-Chain Fatty Acids Following Multi-Species Probiotic Supplementation: Findings from a 12-Week Randomised Placebo-Controlled Trial. Nutrients. https://doi.org/10.3390/nu18071025

Vancouver

Moschonis G, Dacaya P, Truong TT, Amoruso A, Pane M. Modulation of Glucose Homeostasis, Metabolic Endotoxemia and Circulating Short-Chain Fatty Acids Following Multi-Species Probiotic Supplementation: Findings from a 12-Week Randomised Placebo-Controlled Trial. Nutrients. 2026. doi:10.3390/nu18071025

BibTeX
@article{Moschonis2026,
  author = {Moschonis, George and Dacaya, Pauline and Truong, Thy T and Amoruso, Angela and Pane, Marco},
  title = {Modulation of Glucose Homeostasis, Metabolic Endotoxemia and Circulating Short-Chain Fatty Acids Following Multi-Species Probiotic Supplementation: Findings from a 12-Week Randomised Placebo-Controlled Trial},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18071025}
}
Kostenlos starten →